• What we need to know when performing and interpreting US elastography

• Park So-Hyun

• Kim So-Yeon, Suh Chong-Hyun, Lee Seung-Soo, Kim Kyoung-Won, Lee So-Jung, Lee Moon-Gyu

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 406 ~ 414

• Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intra...

• Lee Kyoung-Bun

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 400 ~ 405

• A Korean patient with Guillain-Barre syndrome following acute hepatitis E whose cholestasis resolved...

• Ji Sung-Bok

• Lee Sang-Soo, Jung Hee-Cheul, Kim Hong-Jun, Kim Hyun-Jin, Kim Tae-Hyo, Jung Woon-Tae, Lee ...

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 396 ~ 399

• Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cir...

• Lee Soon-Jae

• Cho Yoo-Kyung, Na Soo-Young, Choi Eun-Kwang, Boo Sun-Jin, Jeong Seung-Uk, Song Hyung-Joo, ...

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 390 ~ 395

• Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-...

• Lee Han-Ah

• Seo Yeon-Seok, Park Seung-Woon, Kim Tae-Hyung, Suh Sang-Jun, Jung Young-Kul, Kim Ji-Hoon, ...

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 382 ~ 389

• Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction...

• Jun Ji-Hye

• Choi Jong-Ho, Bae Si-Hyun, Oh Seh-Hoon, Kim Gi-Jin

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 372 ~ 381

• Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute...

• Kim Jong-Man

• Lee Kwang-Woong, Song Gi-Won, Jung Bo-Hyun, Lee Hae-Won, Yi Nam-Joon, Kwon Choon-Hyuck David,&n...

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 366 ~ 371

• Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein ...

• Jeon Ye-Joo

• Jang Eun-Sun, Choi Yun-Suk, Kim Jin-Wook, Jeong Sook-Hyang

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 359 ~ 365

• Comparison of the clinical outcomes between antiviral-naive patients treated with entecavir and lami...

• Kim Hong-Joo

• Park Soo-Kyung, Yang Hyo-Joon, Jung Yoon-Suk, Park Jung-Ho, Park Dong-Il, Cho Yong-Kyun, S...

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 350 ~ 358

• Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

• Lee Jae-Min

• Yoo Sun-Hong, Sohn Won, Kim Hyung-Woo, Choi Yong-Sun, Won Jung-Ho, Heo Jin-Young, Park San...

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 339 ~ 349

• Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

• Jang Byoung-Kuk

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 336 ~ 338

• Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

• Oh Hyun-Woo

• Jun Dae-Won, Saeed Waqar K, Nguyen Mindie H

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 327 ~ 335

• The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral...

• Varbobitis Ioannis

• Papatheodoridis George V.

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 319 ~ 326

• Liver transplantation for advanced hepatocellular carcinoma

• Lee Hae-Won

• Suh Kyung-Suk

• Clinical and Molecular Hepatology   2016  Volume.22  No.3 309 ~ 318